Table 2.
Epigenetic FTO functions | Transcriptional effects | References |
---|---|---|
FTO-catalyzed demethylation of m6A in mRNAs |
Increased transcription and mRNA stability, modification of m6A-dependent alternative splicing and miRNA binding to target mRNAs | [125–127, 138–143] |
FTO over-expression | Generation of the pro-adipogenic short isoform of RUNX1T1 promoting MCE increasing adipocyte numbers | [145, 146] |
Increased FTO mRNA | Reduction of ghrelin mRNA m6A methylation resulting in increased ghrelin mRNA abundance | [154] |
FTO-deficient MEFs | Reduced protein expression of the mTORC1 activator leucyl-tRNA synthetase | [110] |
Increased FTO expression | Association of FTO CpG hypomethylation in T2DM with recuded m6A levels in mRNA of T2DM patients | [31, 32, 265] |
FTO over-expression | Increased expression of C/EBPβ mRNA, the key transcription factor of gluconeogenesis and adipogenesis | [266, 267] |
FTO over-expression | Loss of stem cell self-renewal capability | [207] |
FTO over-expression | Increased expression of PRL mRNA enhancing PIP expression involved in PC and BC progression | [185–187] |
FTO over-expression | Interaction with APO ϵ4, increasing the risk of AD | [321] |